A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.

Kaposi's sarcoma-associated (KS-associated) herpesvirus (KSHV) is a B-lymphotropic agent linked to AIDS-related lymphoproliferative disorders and KS. We and others have earlier identified two viral genes, K3 and K5, that encode endoplasmic reticulum proteins that downregulate surface MHC-I chains by enhancing their endocytosis. Here we have examined the ability of these proteins to influence the disposition of other host surface proteins implicated in immune recognition and activation. We report that K5, but not K3, expression in BJAB cells dramatically reduces ICAM-1 and B7-2 surface expression; B7-1 expression is unaffected. This K5-induced reduction can be reversed by coexpression of a dominant negative mutant of dynamin, indicating that the loss of ICAM and B7-2 surface expression is due to their enhanced endocytosis. This downregulation is functionally significant, because K5-transfected B cells show substantial impairment in their ability to induce T cell activation. K5 is thus the first example of a viral modulator of immunological synapse formation and T cell costimulation. We propose that its expression reduces T cell responses to KSHV-infected B cells early in infection, thereby diminishing antiviral cytokine release and the production of stimulatory signals for CTL generation.

[1]  M. Corbellino,et al.  Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. , 2001, The Journal of general virology.

[2]  R. Johnson,et al.  Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. , 2000, Immunity.

[3]  P. Lehner,et al.  Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Ganem,et al.  Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Jae U. Jung,et al.  Downregulation of Major Histocompatibility Complex Class I Molecules by Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins , 2000, Journal of Virology.

[6]  M. Munks,et al.  Resting B Lymphocytes as APC for Naive T Lymphocytes: Dependence on CD40 Ligand/CD401 , 2000, The Journal of Immunology.

[7]  S. Constant B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo. , 1999, Journal of immunology.

[8]  S. Jonjić,et al.  Cytomegaloviral control of MHC class I function in the mouse , 1999, Immunological reviews.

[9]  J. Allison,et al.  Costimulatory regulation of T cell function. , 1999, Current opinion in cell biology.

[10]  J. Miller,et al.  TCR, LFA-1, and CD28 play unique and complementary roles in signaling T cell cytoskeletal reorganization. , 1999, Journal of immunology.

[11]  M. Davis,et al.  A receptor/cytoskeletal movement triggered by costimulation during T cell activation. , 1998, Science.

[12]  Graça Raposo,et al.  Antigen-dependent and -independent Ca2+ Responses Triggered in T Cells by Dendritic Cells Compared with B Cells , 1998, The Journal of experimental medicine.

[13]  Patricia L. Widder,et al.  A Novel Adaptor Protein Orchestrates Receptor Patterning and Cytoskeletal Polarity in T-Cell Contacts , 1998, Cell.

[14]  Colin R. F. Monks,et al.  Three-dimensional segregation of supramolecular activation clusters in T cells , 1998, Nature.

[15]  C. Boshoff,et al.  Kaposi's sarcoma herpesvirus as a new paradigm for virus‐induced oncogenesis , 1998, Current opinion in oncology.

[16]  M. Davis,et al.  Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Ploegh Viral strategies of immune evasion. , 1998, Science.

[18]  T. Mak,et al.  Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. , 1997, Immunity.

[19]  U. Koszinowski,et al.  Interference with antigen processing by viruses. , 1997, Current opinion in immunology.

[20]  C. Figdor,et al.  Signalling and adhesive properties of the integrin leucocyte function-associated antigen 1 (LFA-1). , 1997, Biochemical Society transactions.

[21]  P J Blair,et al.  CD28 co-receptor signal transduction in T-cell activation. , 1997, Biochemical Society transactions.

[22]  Michael Loran Dustin,et al.  Making the T cell receptor go the distance: a topological view of T cell activation. , 1997, Immunity.

[23]  E. Simpson,et al.  B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. , 1997, Immunity.

[24]  W. Greene,et al.  c-rel regulation of IL-2 gene expression may be mediated through activation of AP-1 , 1996, The Journal of experimental medicine.

[25]  J. Bluestone,et al.  The Complexities of T‐Cell Co‐stimulation: CD28 and Beyond , 1996, Immunological reviews.

[26]  N. Hogg,et al.  Regulation of leukocyte integrin function: Affinity vs. avidity , 1996, Journal of cellular biochemistry.

[27]  H. Eisen,et al.  Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. , 1996, Immunity.

[28]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[29]  J. Ritz,et al.  Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. , 1996, Experimental hematology.

[30]  J. West,et al.  B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. , 1995, Journal of immunology.

[31]  C G Figdor,et al.  Ins and outs of LFA-1. , 1995, Immunology today.

[32]  M. Croft,et al.  Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. , 1995, Journal of immunology.

[33]  R. Flavell,et al.  Peptide and protein antigens require distinct antigen-presenting cell subsets for the priming of CD4+ T cells. , 1995, Journal of immunology.

[34]  J. Ambroziak,et al.  Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.

[35]  A. Lanzavecchia,et al.  Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton , 1995, The Journal of experimental medicine.

[36]  R C Brower,et al.  Minimal requirements for peptide mediated activation of CD8+ CTL. , 1994, Molecular immunology.

[37]  M. Cooke,et al.  Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. , 1994, Journal of immunology.

[38]  F. Finkelman,et al.  In vivo activation of naive T cells by antigen-presenting B cells. , 1994, Journal of immunology.

[39]  W. Paul,et al.  Lymphocyte responses and cytokines , 1994, Cell.

[40]  D. Parker,et al.  Parameters of tolerance induction by antigen targeted to B lymphocytes. , 1993, Journal of immunology.

[41]  R. Vallee,et al.  Effects of mutant rat dynamin on endocytosis , 1993, The Journal of cell biology.

[42]  C. June,et al.  Costimulation of T cell receptor/CD3-mediated activation of resting human CD4+ T cells by leukocyte function-associated antigen-1 ligand intercellular cell adhesion molecule-1 involves prolonged inositol phospholipid hydrolysis and sustained increase of intracellular Ca2+ levels. , 1992, Journal of immunology.

[43]  L. Lanier,et al.  Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. , 1992, Journal of immunology.

[44]  A. Weiss,et al.  CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation , 1992, The Journal of experimental medicine.

[45]  H. Grey,et al.  The minimal number of class II MHC-antigen complexes needed for T cell activation. , 1990, Science.

[46]  Emil R. Unanue,et al.  Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation , 1990, Nature.

[47]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[48]  L. Lanier,et al.  Comparative studies of human FcRIII-positive and negative natural killer cells. , 1989, Journal of immunology.

[49]  Michael L. Dustin,et al.  T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1 , 1989, Nature.

[50]  B. Benacerraf,et al.  The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. , 1988, Journal of immunology.

[51]  J. Sprent,et al.  T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. , 1987, Journal of immunology.

[52]  S. Dzik,et al.  The immunological synapse: A molecular machine controlling T cell activation , 2000 .

[53]  H. Ploegh,et al.  Viral subversion of the immune system. , 2000, Annual review of immunology.

[54]  J. Yewdell,et al.  Mechanisms of viral interference with MHC class I antigen processing and presentation. , 1999, Annual review of cell and developmental biology.

[55]  V. Kuchroo,et al.  CD28/B7 costimulation: a review. , 1998, Critical reviews in immunology.

[56]  A. Lanzavecchia,et al.  The duration of antigenic stimulation determines the fate of naive and effector T cells. , 1998, Immunity.

[57]  I. Dransfield Regulation of leukocyte integrin function. , 1991, Chemical immunology.

[58]  E. Unanue Antigen-presenting function of the macrophage. , 1984, Annual review of immunology.